Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity.
about
Physiological consequences of drug resistance in Leishmania and their relevance for chemotherapyNew "light" for one-world approach toward safe and effective control of animal diseases and insect vectors from leishmaniac perspectivesBluePort: a platform to study the eosinophilic response of mice to the bite of a vector of Leishmania parasites, Lutzomyia longipalpis sand fliesLeishmaniasis: a review.Modeling of leishmaniasis infection dynamics: novel application to the design of effective therapies.Vaccination with Leishmania infantum acidic ribosomal P0 but not with nucleosomal histones proteins controls Leishmania infantum infection in hamstersCoadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c MiceTransmembrane molecules for phylogenetic analyses of pathogenic protists: Leishmania-specific informative sites in hydrophilic loops of trans- endoplasmic reticulum N-acetylglucosamine-1-phosphate transferase.Phenotypic diversity and selection maintain Leishmania amazonensis infectivity in BALB/c mouse model.The Leishmania infantum acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to Leishmania major infection in BALB/c mice.Mitigating an undesirable immune response of inherent susceptibility to cutaneous leishmaniosis in a mouse model: the role of the pathoantigenic HISA70 DNA vaccine.The Leishmania HSP20 is antigenic during natural infections, but, as DNA vaccine, it does not protect BALB/c mice against experimental L. amazonensis infectionIdentification of novel Leishmania major antigens that elicit IgG2a response in resistant and susceptible mice.Functional paradox in host-pathogen interaction dictates the fate of parasites.Immune response regulation by leishmania secreted and nonsecreted antigens.Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis.In vivo recognition of ovalbumin expressed by transgenic Leishmania is determined by its subcellular localization.Leishmaniasis: clinical syndromes and treatment.Designing and Cloning Molecular Constructs to Knock Out N-Acetylglucosamine Phosphatidylinositol De-N-Acetylase (GPI12) Gene in Leishmania major (MRHO/IR/75/ER).Treatment of Leishmania (Leishmania) Amazonensis-Infected Mice with a Combination of a Palladacycle Complex and Heat-Killed Propionibacterium acnes Triggers Protective Cellular Immune ResponsesGenomic organization of leishmania species.Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?The genetics of Leishmania virulence.Evaluation of an in vitro and in vivo model for experimental infection with Leishmania (Viannia) braziliensis and L. (V.) peruviana.Putative markers of infective life stages in Leishmania (Viannia) braziliensis.Lulo cell line derived from Lutzomyia longipalpis (Diptera: Psychodidae): a novel model to assay Leishmania spp. and vector interaction.Photodynamic sensitization of Leishmania amazonensis in both extracellular and intracellular stages with aluminum phthalocyanine chloride for photolysis in vitroInduction of apoptosis in host cells: a survival mechanism for Leishmania parasites?Leishmania-released nucleoside diphosphate kinase prevents ATP-mediated cytolysis of macrophages.Specific serodiagnosis of canine visceral leishmaniasis using Leishmania species ribosomal protein extracts.Parameter estimation and sensitivity analysis in an agent-based model of Leishmania major infection.Differences in the antigenic profile and infectivity of murine macrophages of Leishmania (Viannia) parasites.Small Myristoylated Protein-3, Identified as a Potential Virulence Factor in Leishmania amazonensis, Proves to be a Protective Antigen against Visceral Leishmaniasis.Effect of A2 gene on infectivity of the nonpathogenic parasite Leishmania tarentolae.Leishmania mexicana: promastigotes and amastigotes secrete protein phosphatases and this correlates with the production of inflammatory cytokines in macrophages.The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing.Searching Genes Encoding Leishmania Antigens for Diagnosis and ProtectionMore than just exosomes: distinct extracellular products potentiate the establishment of infection
P2860
Q24796588-3D28E997-1C1D-41DA-853E-E28644B975F6Q26700044-9A1628DD-AA7D-40E7-87B7-5DDD94DCA9FCQ28748688-38FD9D64-5E39-42A1-AA94-5571CF9F4E13Q33777851-F34B70A3-DF22-4199-A523-DEABC71BA8D4Q34119707-15858F9F-9545-446B-B0F4-4817CAF7A63BQ35038313-2FDE5559-9CA6-4E1B-A3EF-DB8E2DD36588Q35587034-7BD4D583-21B4-467B-B4B9-99521A067956Q35636496-6B294513-AE91-461D-B3FB-850545A08AE5Q36246502-4C936B3B-608D-4237-97C5-DC4644C346FAQ36376320-13F54387-70BA-4A91-AE7C-F717BDF2F6BDQ36415941-AFE63C25-B16F-4355-B7B0-D8CF74302E1CQ36528643-4C790804-27D4-4FE5-83B8-3A98732C20E9Q36868260-323A9ABC-EB3E-480B-960A-DD16C7834F0CQ36903844-2C58071C-7053-4DAE-9E27-DF64D514D2D6Q36915063-642FA4F0-D768-4F23-9C59-C576635253DAQ37225443-72FCFB0A-8CBC-45A3-9F4E-8B8D7A345D35Q37225448-805A2D74-1EF9-455B-8DCA-FC72C3CCF94AQ37406305-3CC5A0A0-9EEE-4CD2-BD75-AD1DDB9807F6Q37597006-4A79E313-A041-4FFD-98DB-A8EB6E1AC7C8Q37681093-DABA3C49-E612-491A-9F88-BA7B19F81B3BQ37985972-1CF629E8-6850-41C0-85FC-608E5C931F9CQ38040818-C5F34ED3-247D-4C47-84FD-FCD7CA9E5A30Q38517526-1DB4E431-21F3-4D9D-893C-4DDE24CE8807Q39016391-67EEBFBE-9FB8-4A8C-9302-36E2E493BBCCQ39016395-F7748A1E-4A55-4B0D-9885-F0DB59135957Q39443427-A86A466A-6076-43A7-BEB4-BD38D850AB54Q39609581-334C1130-B347-4F02-9311-FFF58EC717C8Q39942719-C3A3E43C-3C5F-4900-8F48-8898CE8C7F9EQ40017700-6411DABB-8454-41D0-B58A-9E06E84CE6D4Q42046510-C70839B2-9321-4AF6-ADE7-1AA0D6A29415Q42959562-79AF66A2-0FC4-45BD-9252-06D0CFB9F47BQ43455309-27C83E09-6C92-4B72-BB8B-BA43B5BC60A9Q47232128-08C597E3-69B1-43E9-94D2-23B171CBA2FCQ48059220-F57B37B6-112D-4C19-892A-CC7A97C0C55DQ51318905-2A78188F-9CE5-4B71-9D08-AE2F815EE3D8Q52574669-B48A3373-5FCA-4F25-8575-1B1826BEF748Q58647150-32343BBF-754F-47D9-A686-360A878CC460Q59136686-A4C6764E-1C9E-4439-A724-BEDDED128AE7
P2860
Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Leishmania model for microbial ...... ication and pathoantigenicity.
@ast
Leishmania model for microbial ...... ication and pathoantigenicity.
@en
type
label
Leishmania model for microbial ...... ication and pathoantigenicity.
@ast
Leishmania model for microbial ...... ication and pathoantigenicity.
@en
prefLabel
Leishmania model for microbial ...... ication and pathoantigenicity.
@ast
Leishmania model for microbial ...... ication and pathoantigenicity.
@en
P1433
P1476
Leishmania model for microbial ...... ication and pathoantigenicity.
@en
P2093
Bradford S McGwire
Lynn Soong
P304
P356
10.1016/S0001-706X(02)00238-3
P577
2003-03-01T00:00:00Z